These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15112472)

  • 1. [Effect and tolerability of sequential administration of estradiol valerate and medroxyprogesterone acetate on menopausal symptoms, hormonal profile and biochemical markers in climacteric women].
    Radowicki S; Skórzewska K; Borakowska B; Wierzba W; Michalewski K
    Ginekol Pol; 2004 Jan; 75(1):39-46. PubMed ID: 15112472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
    Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
    Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
    Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
    Egarter C; Geurts P; Boschitsch E; Speiser P; Huber J
    Acta Obstet Gynecol Scand; 1996 Apr; 75(4):386-93. PubMed ID: 8638462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effect of two hormonal preparations in postmenopausal women.
    Bissonnette F; Lussier-Cacan S; Fugère P; Bérubé S
    Maturitas; 1997 Jul; 27(3):275-84. PubMed ID: 9288700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
    Saure A; Planellas J; Poulsen HK; Jaszczak P
    Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term sequential treatment with combined estradiol valerate and cyproterone acetate in early postmenopause.
    Polatti F; Capuzzo E; Viazzo F; Colleoni R; Abbiati I; Nappi RE
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):49-53. PubMed ID: 9926892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V; Sangthawan M
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized cross-over study of a 21-day versus a 28-day hormone replacement therapy (HRT).
    McCarthy T; Dramusic V; Carter R; Costales A; Ratnam SS
    Maturitas; 1995 Jun; 22(1):13-23. PubMed ID: 7666812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hormone replacement therapy and calcitonin on bone mass in postmenopausal women.
    Meschia M; Brincat M; Barbacini P; Maini MC; Marri R; Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 1992 Oct; 47(1):53-7. PubMed ID: 1330761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
    Dören M; Reuther G; Minne HW; Schneider HP
    Am J Obstet Gynecol; 1995 Nov; 173(5):1446-51. PubMed ID: 7503183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women.
    Yang TS; Tsan SH; Chen CR; Chang SP; Yuan CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):308-15. PubMed ID: 10389286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of estrogen supplementation on psychological variables in climacteric women].
    Gramegna G; Blümel JE; Jara S; Schiattino I; Lolas F
    Rev Med Chil; 1996 Oct; 124(10):1240-4. PubMed ID: 9239913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with transcutaneous estradiol and oral medroxyprogesterone acetate.
    Pedersen OD; Jensen HK
    Acta Obstet Gynecol Scand; 1992 Dec; 71(8):593-8. PubMed ID: 1336917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of estradiol valerate and chlormadinone acetate in hormone replacement therapy in postmenopause on Kupperman index, body weight, blood pressure, lipids, enzymes and electrolytes].
    Göretzlehner G; Nikschick S; Zimmermann T
    Zentralbl Gynakol; 1996; 118(7):420-5. PubMed ID: 8766107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone substitution treatment of the menopause].
    González-Merlo J; Castelo-Branco C; Celades M
    Rev Med Univ Navarra; 1992; 37(3):143-51. PubMed ID: 1336213
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrine effects in Asian postmenopausal women treated with SH D 461 M and Prempak-C.
    Goh HH; McCarthy TG; Dramusic V; Costales A; Junge W; Ratnam SS
    Maturitas; 1994 Dec; 20(2-3):165-73. PubMed ID: 7715469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.